Nuwellis, Inc. (NASDAQ:NUWE) Sees Large Increase in Short Interest

Nuwellis, Inc. (NASDAQ:NUWE) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 558,100 shares, an increase of 67.8% from the January 15th total of 332,600 shares. Based on an average trading volume of 1,000,000 shares, the days-to-cover ratio is presently 0.6 days. Approximately 49.8% of the shares of the company are short sold.

Institutional Trading of Nuwellis

An institutional investor recently bought a new position in Nuwellis stock. Geode Capital Management LLC purchased a new stake in Nuwellis, Inc. (NASDAQ:NUWE) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned about 0.70% of Nuwellis at the end of the most recent reporting period. 3.13% of the stock is owned by institutional investors.

Nuwellis Price Performance

NUWE stock traded down $0.01 during trading hours on Friday, reaching $1.29. The stock had a trading volume of 149,008 shares, compared to its average volume of 1,079,352. The stock has a market capitalization of $5.64 million, a PE ratio of -0.01 and a beta of 0.31. The stock has a 50-day simple moving average of $1.17 and a 200 day simple moving average of $1.48. Nuwellis has a fifty-two week low of $0.92 and a fifty-two week high of $27.61.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.